Curaleaf Margins Suffer from Price Compression, but Hope Remains
Price pressure has been a common theme in this round of cannabis earnings, and Curaleaf Holdings
Alabama Redoes Medical Marijuana Licensing, Some Original Winners Lose Out
Verano says it will “pursue all options to defend our rightfully earned Integrated Facilities License.”
The Daily Hit: August 10, 2023
The Daily Hit is a recap of the top financial news stories for Aug. 10,
Aurora Cannabis Revenues Skyrocket But Still a Losing Quarter
Aurora’s plant propagation business helped drive the revenue boost. Canada-based Aurora Cannabis Inc. (Nasdaq: ACB)
TerrAscend Builds in Key Markets to Beat Q2 Analyst Expectations
Management previously suggested that 2023 could be a breakthrough year. TerrAscend Corp. (TSX: TSND) (OTCQX:
Leafly Boosted by Cost-Cutting Measures Despite Sales Slump
Retail partnership spending fell during the period. Online cannabis discovery platform Leafly Holdings Inc. (Nasdaq:
Flora Growth Posts 140% Revenue Surge Amid Q2 Losses
The CEO said that company is focused on streamlining. Flora Growth Corp. (Nasdaq: FLGC) reported
Dr. Bronner’s Workers Who Received Company-Funded Ketamine Therapy Coverage Report ‘Dramatic Improvements’ In Mental Health
A first-of-its-kind health care provider has released top-level findings from its ketamine treatment plan for
Atai Moves Forward With Studies With Solid Cash Position
Atai Life Sciences (NASDAQ: ATAI) reported its second quarter 2023 financial results and provided corporate
Rhode Island Marijuana Regulators Hear Demands About Equity And Other Issues During Listening Tour
“The very people that are benefiting from the legalization of weed aren’t the people that